Current Edition

Upcoming Events

Advertisement

news

AACR 2022: NK cell promise, more TIGIT questions and extending CAR-T’s reach

Each year, the American Association for Cancer Research’s conference spotlights promising early research into new approaches for attacking tumors. This year's meeting...
Continue Reading →
news

Bristol Myers gets FDA decision date for earlier use of CAR-T therapy

Dive Brief: The Food and Drug Administration will decide whether to approve Bristol Myers Squibb's cancer cell therapy Breyanzi for earlier use by late June, the c...
Continue Reading →